Developing Computerised CBT for Adults With OCD
CCBT
Developing Computerised Cognitive Behavioural Therapy for Adults With Obsessive-compulsive Disorder
2 other identifiers
interventional
12
1 country
2
Brief Summary
The study aims to pilot a new computerised cognitive behavioural therapy programme for a small case series of adults with obsessive-compulsive disorder. The investigators hypothesise that the findings will demonstrate improvements in symptomatology following the programme. The programme will have longer-term aims of being rolled out over a number of IAPT services within the NHS, reducing waiting lists and increasing therapist time.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for early_phase_1
Started Oct 2015
Typical duration for early_phase_1
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 4, 2014
CompletedFirst Posted
Study publicly available on registry
March 25, 2015
CompletedStudy Start
First participant enrolled
October 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedAugust 30, 2016
February 1, 2016
2 years
June 4, 2014
August 29, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Y-BOCS-OCD
Yale-Brown Obsessive-Compulsive Scale for OCD. Questions focus on obsessive thoughts participants may have along with behaviours they feel compelled to do in order to reduce their anxiety. This outcome is expected to change (improve) from baseline throughout the trial as a result of the computerised CBT.
baseline, week 3, week 4 or week 5 after baseline, 12 weeks, 1 month follow-up
Secondary Outcomes (8)
Psychiatric Diagnostic Screening Questionnaire
baseline
DSM-IV OCD SCID
baseline
Patient Health Questionnaire
baseline, week 3, week 4 or week 5 after baseline, 12 weeks, 1 month follow-up
Generalised anxiety disorder assessment
baseline, week 3, week 4 or week 5 after baseline, 12 weeks, 1 month follow-up
Work and social adjustment scale
baseline, week 3, week 4 or week 5 after baseline, 12 weeks, 1 month follow-up
- +3 more secondary outcomes
Study Arms (1)
Computerised CBT
EXPERIMENTALComputerised CBT for OCD
Interventions
Eligibility Criteria
You may qualify if:
- Adults aged 18 or over with OCD as defined by DSM-IV who are seeking CBT.
- The patient describes their OCD as their main problem and scores between 14 and 30 on the YBOCS (Goodman et al, 1989). A score above 30 is in the severe range and indicates that the CBT should probably be therapist delivered.
- Able to use self-help materials in English and answer written questionnaires.
- Able to access the internet (either at home or in a public library or drop in centre or at the clinic).
- Have a current episode of OCD of more than 6 months in duration.
You may not qualify if:
- Significant and complex co-morbidity (e.g. significant personality disorder, severe depression or alcohol dependence, which requires longer therapy or is more difficult to treat). Such patients are likely to be part of a Community Mental Health team or be funded by the Department of Health's National Specialist Commissioning Team scheme for severe treatment refectory OCD.
- Current active suicidal intent or severe self-neglect that requires hospitalisation.
- The patient has a primary problem of compulsive hoarding (as such patients are more complex or are more likely to be under a Community Mental Health team).
- Continuing to receive another form of psychotherapy.
- Has received CBT for OCD in the past year.
- A participant may be taking an anti-depressant for OCD but must be on a stable dose for at least 12 weeks prior to entry in the trial with no plans to alter the dose during the trial period. There must also be no plan to commence on an anti-depressant or anti-psychotic medication. (Participants excluded because of their current or planned medication may be offered a further assessment for the trial after being on a stable dose
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Centre for Anxiety Disorders and Trauma
London, London, SE5 8AZ, United Kingdom
South London and Maudsley NHS Trust
London, SE5 8AZ, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Veale, MRCPsych
Institute of Psychiatry
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
June 4, 2014
First Posted
March 25, 2015
Study Start
October 1, 2015
Primary Completion
October 1, 2017
Study Completion
December 1, 2017
Last Updated
August 30, 2016
Record last verified: 2016-02